Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate the validity and Inter-rater reliability for early recognition of spasticity by nurses and physiotherapists using the decision tree tool.


Clinical Trial Description

The Spastic Movement Disorder (SMD) Decision Tree was designed as a tool to aid nurses, therapists and other healthcare professions recognize potential signs of disabling spasticity in the upper limb of post-stroke patients. The present study assesses validity and inter-rater reliability of the SMD Decision Tree comparing nurses and therapists with gold-standard procedure performed by rehabilitation doctors. Agreement was tested for "referral to specialist indicated" and "no referral to specialist indicated". ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06381999
Study type Observational
Source Merz Pharmaceuticals GmbH
Contact
Status Completed
Phase
Start date October 27, 2023
Completion date February 26, 2024

See also
  Status Clinical Trial Phase
Completed NCT00460564 - Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity Phase 3
Completed NCT00460655 - Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity Phase 3
Completed NCT03251521 - Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment N/A
Completed NCT01251367 - Dysport® Adult Lower Limb Spasticity Follow-on Study Phase 3